Avicanna: A Leader in Biopharmaceutical Advancements Using Cannabinoids
Aras Azadian, CEO of Avicanna Inc. discusses why their are positioned to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and extracts throughout North America, Latin America, Europe and Asia.
Join us at an upcoming event! http://www.cambridgehouse.com
Be part of our investment community:
Copyright © 2019 Cambridge House International Inc. All rights reserved.